Finally, the beneficial effects of leucine supplementation in this trial seem unrelated to changes in inflammatory markers in blood such as leucocyte counts, reactive C- protein, IL-6 and TNF-alpha, which have all been associated with sarcopenia [41,54,55,56]. This evidence concerns the gene CRP and sarcopenia.